The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Couldn’t agree more that significant compensation is unlikely even if the case is won. Better not to bank on that. However, if winning unlocks more sales that’s good enough for me.
Yep. It’s not budged as far as I can see.
…..early in the New Year, I would guess.
I will say something constructive. They are not cash strapped, fortunately , after the disposal of the lithium claim blocks. This buys them some time. They are also constraining costs to conserve cash. It would not be accurate to suggest that they are about to go bust anytime soon.
Interesting articles but, as HD 10 speculated, they appear to relate to a specific manufacturing process for a particular type of plastic (in the case of the Guardian article, by a specific manufacturer) not Symphony’s products. Whilst Sym’s products may not solve the problem of PFAS being produced by some manufacturer’s products (and that clearly needs to be addressed by those manufacturers/the Regulators) they clearly do represent solutions to a number of important problems resulting from use of plastics, not least the millions of tons of the stuff floating around our seas. If D2W was used more widely (and fortunately some enlightened counties have mandated use of such technology) any plastic that avoided recycling efforts and escaped into the open environment would rapidly degrade into harmless organic material (save perhaps for the persistence of PFAS chemicals if the manufacturer chooses to adopt the manufacturing process that produces them in the first place). I say perhaps because although I note that the thing about “forever chemicals” is that they don’t naturally degrade in the environment, it would be interesting to find out if the addition of D2W helps in that respect.
Let’s not forget:
1) The company reported cash in the bank of $4.5m as at 30/09/23 (following the ERBSs’s investment at 42.3p)plus AUD940,000 from options; and
2) They have an allocated grant from the European Just Transition Fund of €49m for early programme works, just awaiting permitting etc.
3) Keith’s background is in finance.
I will let anyone reading some of the comments on this board draw their own conclusions from the above. Keith was on Proactive only a month or so ago and was confident then that the DFS would be out by the year end. He would be keen, I would have thought, to get it out for the AGM, but even if it slips into January, I don’t really give a monkey’s wotsit because this is a no brainer of an investment in my view , especially at this silly price. That is just my opinion of course, not advice, and do your own research and all that jazz.
Well, after a lot of thought, I have bitten the bullet and almost tripled my shareholding at a fraction of the price of my original holing to reduce my average from over 23p to under 10p. It just seems way too cheap. “Buy when there is blood on the streets” etc. Its got to recover at some point. The gold is still sitting there. They have enough cash to sit it out.
I would very much doubt it but why not ask the company if you are concerned about that?
I truly hope the regulators investigate this lot, but I won’t hold my breath on that!
I reckon this partnership could resolve the question why haven’t we seen more sales to date? Answer: the lack, until now, of consistent coverage on the high seas. I reckon this partnership could unlock some substantial orders.
Well, just topped up by another £1k at 4p. Well worth the risk in my opinion at this price, but each to their own, DYOR etc.
I am not so far under water, although bad enough, at 9.7p but personally I think you will eventually get your money back. The AIM market in general has been dire but will presumably pick up at some point and this company looks to me as if it’s not far away from break even and then profit.
So, for what it’s worth, having listened to the presentation, this is what I heard:
1) DFS should be “completed” by the end of this year.
2) DFS to be “released” early next year.
3) Off take discussions with European companies (no Asian companies as they want to keep the whole of the value chain in Europe) at a very advanced stage and could possibly be completed before the DFS, but in any event around the same time.
4) Results of final test work “imminent “..
Mat- I hope you are well. I haven’t checked back for the detail but I presume the stock sold by the family office back then was sold at a profit? If so, leaving out considerations for other shareholders, it could be seen as a shrewd move. Likewise, buying stock now when the sp is on its knees, could also be seen as shrewd, assuming the assets/cash are worth what we are told. I sold out of seed a while back as I was disillusioned with progress or lack of (albeit part, perhaps most, of the blame could be laid at the door of the market in general over the last year or two). However, I have just dipped my toe in again on the back of Mellon’s buy. To me, it looks like a pretty good sign, no?